N6HB426-20 is a monoclonal antibody developed to block HBV infection by targeting NTCP, the primary receptor for HBV and hepatitis D virus (HDV) entry into hepatocytes. Unlike conventional therapies that suppress viral replication, N6HB426-20 prevents viral entry, offering a novel strategy for chronic hepatitis B treatment .
Key targets and interactions:
NTCP extracellular domain binding: N6HB426-20 recognizes residues Pro276/Glu277 (P276/E277) at the tip of extracellular loop 4 (ECL4) of NTCP .
Steric interference: The antibody disrupts HBV’s interaction with critical NTCP regions required for viral entry, specifically residues 84–87 (ECL1) and 157–165 (near ECL2) .
Selective inhibition: While blocking HBV/HDV entry, it minimally affects NTCP’s native bile acid transport function .
Clinical relevance:
N6HB426-20 remains effective across HBV genotypes and in the presence of noninfectious HBsAg particles .
KEGG: sce:YBR188C
STRING: 4932.YBR188C
NTC20 antibody is a polyclonal antibody that specifically recognizes Ntc20, a component of the Prp19-associated complex (NTC). The NTC complex is essential for pre-mRNA splicing and is associated with the spliceosome during spliceosome activation. NTC plays a critical role in specifying interactions of U5 and U6 with pre-mRNA to stabilize their association with the spliceosome after dissociation of U4 .
Researchers use anti-Ntc20 antibodies to study spliceosome dynamics, isolate NTC-associated complexes, and investigate protein interactions within the splicing machinery. The antibody serves as a valuable tool for monitoring the presence and behavior of Ntc20 during various stages of the splicing reaction .
According to the search results, anti-Ntc20 antibodies are commonly produced by immunizing rabbits with full-length recombinant Ntc20 proteins expressed in Escherichia coli . This approach generates polyclonal antibodies that recognize multiple epitopes on the Ntc20 protein, enhancing their utility for various experimental applications.
The production process typically involves:
Expressing and purifying full-length recombinant Ntc20 protein in E. coli
Immunizing rabbits with the purified protein following standard immunization protocols
Collecting antisera containing polyclonal antibodies against Ntc20
Optionally purifying the antibodies using affinity chromatography to enhance specificity
This method yields antibodies with high specificity and affinity for Ntc20, making them suitable for applications such as immunoprecipitation, Western blotting, and immunodepletion experiments .
Immunoprecipitation experiments using anti-Ntc20 antibodies can pull down various components of the spliceosome machinery. Based on the search results, several proteins have been found to associate with Ntc20 in these experiments:
Other NTC components, including Prp19, Ntc90, Ntc85, Ntc77, Ntc31, Ntc30, and Ntc25
Yju2, a novel splicing factor that associates with components of NTC
The specific components that co-precipitate with Ntc20 may vary depending on the stage of the splicing reaction and experimental conditions. For instance, Yju2 is associated with the spliceosome at nearly the same time as NTC but is destabilized after the first catalytic reaction, whereas other NTC components remain associated until the reaction is complete .
Based on the search results, the recommended protocol for immunoprecipitation using anti-Ntc20 antibody typically follows these steps:
Antibody quantity: Use 1 μl of anti-Ntc20 antibody for each 10 μl of splicing reaction .
Substrate preparation: Synthesize actin precursors in vitro using SP6 RNA polymerase according to established methods. Alternatively, use biotinylated pre-mRNA synthesized following procedures described in the literature .
Immunoprecipitation procedure: Incubate splicing reaction mixtures with antibody-conjugated Protein A-Sepharose (PAS) at 4°C for 1 hour .
Washing and elution: After centrifugation, wash the precipitates four times with 1 ml of NET-2 buffer (50 mM Tris–HCl, pH 7.4, 150 mM NaCl, and 0.05% NP-40) .
Analysis: Extract RNA from the precipitates for subsequent analysis by standard methods .
This protocol allows for the efficient isolation of Ntc20-containing complexes from splicing reactions, enabling researchers to study the composition and dynamics of these complexes during the splicing process .
Immunodepletion of Ntc20 or NTC components can be critical for functional studies. Based on the search results, a typical immunodepletion protocol involves:
Antibody preparation: Conjugate anti-Ntc20 antibody to Protein A-Sepharose. The specific amount may vary depending on the experiment, but based on similar depletions described in the search results, approximately 200 μl of antibody conjugated to 100 μl PAS may be appropriate .
Depletion procedure: Incubate yeast splicing extracts with the antibody-conjugated PAS at 4°C for 1 hour .
Collection of depleted extracts: After centrifugation, collect the supernatant fractions as depleted extracts and store at –80°C .
Validation: Confirm depletion efficiency by Western blot analysis of the depleted extract compared to a mock-depleted control.
Functional analysis: Assess the functional consequences of Ntc20 depletion by conducting splicing assays with the depleted extracts and analyzing the formation of splicing intermediates and products .
Researchers should note that immunodepletion experiments using anti-Ntc20 antibody can help determine the specific role of Ntc20 in splicing reactions and its interactions with other spliceosomal components .
The NTC20 antibody offers valuable insights into the dynamic interactions between splicing factors. Based on the search results, researchers can use this antibody to:
Track temporal associations: Monitor the association and dissociation of factors during different stages of splicing. For example, Yju2 associates with the spliceosome at nearly the same time as NTC but dissociates after the first catalytic reaction, while NTC components remain associated until completion .
Identify interaction partners: By immunoprecipitating Ntc20-containing complexes at different stages of splicing, researchers can identify proteins that associate with NTC in a stage-specific manner .
Assess dynamic interactions: The search results describe experiments where recombinant His-Yju2 was added to splicing extracts, followed by immunoprecipitation of NTC to determine whether His-Yju2 became newly associated with NTC. This approach revealed that Yju2 can interact dynamically with NTC components .
RNase treatment experiments: By treating extracts with RNase A before immunoprecipitation, researchers can determine whether interactions between Ntc20 and other proteins are mediated through RNA or represent direct protein-protein interactions .
An example from the search results demonstrated that association of Yju2 with NTC was not mediated through RNA binding, as pretreatment of extracts with RNase A did not affect the association .
The NTC20 antibody serves as a critical tool for investigating spliceosome assembly and activation processes:
Spliceosome isolation: Anti-Ntc20 antibody can be used to isolate spliceosomes at specific assembly stages, allowing researchers to study the composition and structure of these complexes .
NTC-mediated activation: The search results indicate that NTC is required for specifying interactions of U5 and U6 with pre-mRNA to stabilize their association with the spliceosome after U4 dissociation. Anti-Ntc20 antibody can help researchers study this critical activation step .
Sequential factor recruitment: By using anti-Ntc20 antibody in combination with antibodies against other splicing factors, researchers can determine the order of factor recruitment during spliceosome assembly .
Spliceosome stability assays: Anti-Ntc20 antibody can be employed in spliceosome stability assays to assess how different factors contribute to the structural integrity of the splicing complex .
The search results describe experiments where factors like Yju2 were found to act after Prp2-mediated structural rearrangement of the spliceosome, highlighting how anti-Ntc20 antibody can help dissect the sequential steps of spliceosome activation and catalysis .
When designing experiments with NTC20 antibody, researchers should include several critical controls:
Non-immune serum control: Include a control immunoprecipitation using pre-immune serum or an irrelevant antibody of the same isotype to assess non-specific binding.
Input sample: Always analyze an aliquot of the starting material (input) alongside immunoprecipitated samples to evaluate precipitation efficiency.
RNase treatment control: As demonstrated in the search results, RNase A treatment can help determine whether observed interactions are RNA-dependent or represent direct protein-protein interactions .
Antibody specificity validation: Confirm the specificity of the anti-Ntc20 antibody using extracts from strains where Ntc20 is tagged (e.g., with HA) by comparing immunoprecipitation results with anti-HA and anti-Ntc20 antibodies .
Mock depletion control: For immunodepletion experiments, include a mock-depleted extract treated with non-immune IgG to control for non-specific effects of the depletion procedure .
These controls help ensure that results obtained with anti-Ntc20 antibody accurately reflect the biological roles and interactions of Ntc20 in splicing processes .
Optimizing antibody specificity is crucial for obtaining reliable results in complex experimental systems. Based on the search results and general immunological principles, researchers can:
Affinity purification: Purify the anti-Ntc20 antibody using affinity chromatography with immobilized recombinant Ntc20 protein to enrich for specific antibodies.
Titration experiments: Determine the optimal antibody concentration for each application by performing titration experiments. The search results indicate that 1 μl of anti-Ntc20 antibody is appropriate for 10 μl of splicing reaction in immunoprecipitation experiments .
Pre-clearing: Pre-clear extracts with Protein A-Sepharose before adding the specific antibody to reduce non-specific binding.
Blocking agents: Include appropriate blocking agents (e.g., BSA, non-fat dry milk) in buffers to minimize non-specific interactions.
Stringency optimization: Adjust the stringency of washing buffers (salt concentration, detergent type and concentration) to balance between specific signal retention and background reduction.
By implementing these strategies, researchers can enhance the specificity of anti-Ntc20 antibody in their experiments, leading to more reliable and interpretable results .
Researchers may encounter several challenges when working with NTC20 antibody:
Low immunoprecipitation efficiency:
Problem: Insufficient pull-down of Ntc20-containing complexes
Solution: Increase antibody amount, optimize incubation conditions, or use crosslinking approaches to stabilize transient interactions
High background in co-immunoprecipitation experiments:
Problem: Non-specific proteins appearing in immunoprecipitates
Solution: Increase washing stringency, pre-clear extracts, or use more specific antibody preparations
Inconsistent results between experiments:
Problem: Variability in antibody performance across batches
Solution: Standardize antibody production and validation, use monoclonal antibodies when possible, or pool validated antibody batches
Difficulty detecting low-abundance complexes:
Problem: Inability to detect rare Ntc20-containing complexes
Solution: Scale up starting material, use more sensitive detection methods, or employ signal amplification techniques
Cross-reactivity with related proteins:
Problem: Antibody recognizing proteins other than Ntc20
Solution: Validate antibody specificity using Ntc20 deletion strains or perform competitive binding assays with purified Ntc20 protein
By addressing these challenges systematically, researchers can improve the reliability and reproducibility of their experiments using NTC20 antibody .
The anti-Ntc20 antibody can be integrated with various techniques to provide comprehensive insights into splicing mechanisms:
Mass spectrometry: Combine immunoprecipitation using anti-Ntc20 antibody with mass spectrometry to identify novel interaction partners of Ntc20 and characterize the composition of Ntc20-containing complexes at different splicing stages.
Chromatin immunoprecipitation (ChIP): Use anti-Ntc20 antibody in ChIP experiments to investigate co-transcriptional splicing and the association of NTC components with nascent transcripts.
UV cross-linking analysis: As mentioned in the search results, anti-Ntc20 antibody can be used alongside UV cross-linking techniques to identify direct RNA-protein interactions involving Ntc20 or associated factors .
Primer extension analysis: The search results indicate that primer extension analysis can be combined with immunoprecipitation using anti-Ntc20 antibody to map sites of protein-RNA interactions within the spliceosome .
Structural studies: Use anti-Ntc20 antibody to isolate native spliceosomes for structural analysis using cryo-electron microscopy or other structural biology techniques.
These integrated approaches can provide deeper insights into the structural and functional roles of Ntc20 and the NTC complex in pre-mRNA splicing .
The performance of different antibodies against NTC components can vary significantly:
This comparison highlights that anti-Ntc20 antibody is among the more efficient options for immunoprecipitation of spliceosomal complexes, requiring relatively small volumes compared to antibodies against some other components .
Comparing results obtained with anti-Ntc20 antibody to those from antibodies against other splicing factors can provide valuable insights:
Temporal dynamics: The search results indicate that factors like Yju2 associate with the spliceosome at nearly the same time as NTC but dissociate after the first catalytic reaction, while NTC components remain associated until completion. Comparing immunoprecipitations with anti-Ntc20 and anti-Yju2 antibodies at different time points can reveal these temporal dynamics .
Complex composition: Different antibodies may pull down distinct subcomplexes. For example, anti-Ntc20 precipitates NTC components, while anti-Cwc23 or anti-Ntr1 antibodies precipitate NTR complex components .
Functional relationships: Comparing the effects of immunodepleting different factors (e.g., Ntc20 vs. Yju2) can reveal their functional relationships and dependencies. The search results show that Yju2 is not required for the binding of NTC to the spliceosome or for NTC-mediated spliceosome activation .
Protein interaction networks: Two-hybrid assays revealed that Yju2 interacts specifically with Ntc90 and Ntc77 but not with other NTC components including Ntc20. Comparing immunoprecipitation results with different antibodies can help map these interaction networks .
By systematically comparing results obtained with different antibodies, researchers can construct a more comprehensive understanding of the dynamic assembly, composition, and function of the spliceosome .